Skip to content

Back

FDADrugsRecalled

Brandywine Pharmaceuticals, LLC recalls Theophylline Extended-Release Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Read the official notice on accessdata.fda.gov
What's wrong
CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory
Products
  • Theophylline Extended-Release Tablets
Company
Brandywine Pharmaceuticals, LLC
Where it was sold

Nationwide within U.S

Units affected
1,332 100-count bottles
Status
Ongoing

Recall Relay is not affiliated with or endorsed by FDA or any agency. Details here are copied from the FDA notice and may lag behind it; the official notice is always the final word.